GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (GREY:PMKIF) » Definitions » Total Liabilities

PT Merck Tbk (PT Merck Tbk) Total Liabilities : $16.07 Mil (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is PT Merck Tbk Total Liabilities?

PT Merck Tbk's Total Liabilities for the quarter that ended in Mar. 2024 was $16.07 Mil.

PT Merck Tbk's quarterly Total Liabilities declined from Sep. 2023 ($11.82 Mil) to Dec. 2023 ($10.50 Mil) but then increased from Dec. 2023 ($10.50 Mil) to Mar. 2024 ($16.07 Mil).

PT Merck Tbk's annual Total Liabilities declined from Dec. 2021 ($23.98 Mil) to Dec. 2022 ($17.83 Mil) and declined from Dec. 2022 ($17.83 Mil) to Dec. 2023 ($10.50 Mil).


PT Merck Tbk Total Liabilities Historical Data

The historical data trend for PT Merck Tbk's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Merck Tbk Total Liabilities Chart

PT Merck Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.09 22.49 23.98 17.83 10.50

PT Merck Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.61 12.59 11.82 10.50 16.07

PT Merck Tbk Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PT Merck Tbk's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8.11+(0.726+0.01
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+1.658)
=10.50

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=62.131-51.627
=10.50

PT Merck Tbk's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=13.384+(0.926+0.016000000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+1.748)
=16.07

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=69.236-53.161
=16.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Merck Tbk Total Liabilities Related Terms

Thank you for viewing the detailed overview of PT Merck Tbk's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Merck Tbk (PT Merck Tbk) Business Description

Traded in Other Exchanges
Address
Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines to treat cancer, multiple sclerosis, infertility, growth disorders, and cardiovascular and metabolic diseases, as well as chronic diseases.

PT Merck Tbk (PT Merck Tbk) Headlines

No Headlines